For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.
Limited to conditions with 5 or more bacteria
Name | Overlap Percent | Prevalance in Population | Matches | Bacteria in From | Bacteria in To |
---|---|---|---|---|---|
Allergies | 44 % | 30% | 22 | 50 | 678 |
Alzheimer's disease | 58 % | 10% | 29 | 50 | 678 |
Autism | 52.7 % | 2% | 58 | 110 | 678 |
Ulcerative colitis | 54.6 % | 0.1% | 59 | 108 | 678 |
Rosacea | 36.4 % | 5.46% | 8 | 22 | 678 |
Schizophrenia | 39.8 % | 0.75% | 37 | 93 | 678 |
Ankylosing spondylitis | 51 % | 7% | 265 | 520 | 678 |
Mood Disorders | 100 % | 29.7% | 6 | 6 | 678 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 48.5 % | 0.86% | 65 | 134 | 678 |
Psoriasis | 58.7 % | 3% | 27 | 46 | 678 |
Multiple Sclerosis | 48 % | 0.5% | 48 | 100 | 678 |
Obesity | 36.5 % | 42.4% | 38 | 104 | 678 |
Osteoporosis | 59.1 % | 9.4% | 13 | 22 | 678 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 39.5 % | 0.005% | 17 | 43 | 678 |
neuropsychiatric disorders (PANDAS, PANS) | 53.3 % | 0.1% | 8 | 15 | 678 |
ME/CFS without IBS | 53.8 % | 0.4% | 14 | 26 | 678 |
Obesity | 69.1 % | 42.4% | 38 | 55 | 678 |
Multiple system atrophy (MSA) | 61.9 % | 0.005% | 13 | 21 | 678 |
Metabolic Syndrome | 28.6 % | 21% | 2 | 7 | 678 |
ME/CFS with IBS | 84.2 % | 2.8% | 16 | 19 | 678 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 44.7 % | 25% | 34 | 76 | 678 |
Parkinson's Disease | 34.4 % | 1% | 31 | 90 | 678 |
Insomnia | 60 % | 30% | 6 | 10 | 678 |
Chronic Kidney Disease | 54.3 % | 15% | 19 | 35 | 678 |
Systemic Lupus Erythematosus | 43.9 % | 0.15% | 29 | 66 | 678 |
Depression | 43.2 % | 8% | 35 | 81 | 678 |
Irritable Bowel Syndrome | 53.2 % | 15% | 33 | 62 | 678 |
IgA nephropathy (IgAN) | 55.2 % | 0.001% | 16 | 29 | 678 |
Chronic Urticaria (Hives) | 47.8 % | 5% | 11 | 23 | 678 |
Hyperlipidemia (High Blood Fats) | 32 % | 33% | 8 | 25 | 678 |
hypercholesterolemia (High Cholesterol) | 44.4 % | 12% | 4 | 9 | 678 |
hypertension (High Blood Pressure | 50 % | 47% | 3 | 6 | 678 |
Allergic Rhinitis (Hay Fever) | 41.7 % | 7.8% | 15 | 36 | 678 |
gallstone disease (gsd) | 80 % | 5% | 12 | 15 | 678 |
Graves' disease | 50 % | 0.5% | 4 | 8 | 678 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 46.7 % | 1% | 14 | 30 | 678 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 54.2 % | 27.8% | 13 | 24 | 678 |
Fibromyalgia | 67.6 % | 1.12% | 25 | 37 | 678 |
Functional constipation / chronic idiopathic constipation | 48.8 % | 14% | 20 | 41 | 678 |
Gout | 33.3 % | 6.8% | 7 | 21 | 678 |
Epilepsy | 36 % | 0.84% | 9 | 25 | 678 |
Cerebral Palsy | 88.2 % | 0.2% | 15 | 17 | 678 |
Inflammatory Bowel Disease | 51.5 % | 1.3% | 34 | 66 | 678 |
Type 1 Diabetes | 53.8 % | 0.19% | 28 | 52 | 678 |
COVID-19 | 38.9 % | 50% | 14 | 36 | 678 |
Carcinoma | 84.3 % | 1% | 43 | 51 | 678 |
Colorectal Cancer | 39.2 % | 4.3% | 116 | 296 | 678 |
Celiac Disease | 46.3 % | 1.4% | 31 | 67 | 678 |
Chronic Fatigue Syndrome | 61.8 % | 3% | 34 | 55 | 678 |
Crohn's Disease | 63.1 % | 0.3% | 89 | 141 | 678 |
Coronary artery disease | 50 % | 6.7% | 8 | 16 | 678 |
Barrett esophagus cancer | 43.8 % | 7% | 7 | 16 | 678 |
Bipolar Disorder | 48.5 % | 3% | 16 | 33 | 678 |
Asthma | 44.4 % | 8% | 12 | 27 | 678 |
Atherosclerosis | 52.3 % | 50% | 274 | 524 | 678 |
Acne | 47.4 % | 47% | 9 | 19 | 678 |
Generalized anxiety disorder | 42.9 % | 2.7% | 6 | 14 | 678 |
Small Intestinal Bacterial Overgrowth (SIBO) | 50 % | 52% | 8 | 16 | 678 |
Brain Trauma | 63.6 % | 0.367% | 14 | 22 | 678 |
Sjögren syndrome | 65.9 % | 1.2% | 27 | 41 | 678 |
Type 2 Diabetes | 50.9 % | 10.8% | 136 | 267 | 678 |
Stress / posttraumatic stress disorder | 60.7 % | 5.2% | 34 | 56 | 678 |
ADHD | 38.3 % | 9.4% | 18 | 47 | 678 |
Hashimoto's thyroiditis | 57.1 % | 0.35% | 8 | 14 | 678 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.